NEW YORK (GenomeWeb News) – The biotechnology entrepreneur Alejandro Zaffaroni, who co-founded Affymetrix, has died at the age of 91, The New York Times has reported.

Originally from Uruguay, Zaffaroni helped to launch biotechnology and Silicon Valley companies beyond Affymetrix, including Alza, Syntex, Perlegen Sciences, Symyx Technologies, DNAX, and Maxygen. He also had a hand in bringing new technologies to market, including Affymetrix's biochips, as well as the birth control pill and the nicotine patch.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.